Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).

Blood cancer journal - 6 Dec 2019

Beird Hannah C, Khan Maliha, Wang Feng, Alfayez Mansour, Cai Tianyu, Zhao Li, Khoury Joseph, Futreal P Andrew, Konopleva Marina, Pemmaraju Naveen

Abstract excerpt

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, male-predominant hematologic malignancy with poor outcomes and with just one recently approved agent (tagraxofusp). It is characterized by the abnormal proliferation of precursor plasmacytoid dendritic cells (pDCs) with morphologic and molecular similarities to acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)/chronic myelomonocytic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Alleles

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Computational Biology

Share to Dendritic Cells

Share to Disease Susceptibility

Share to Gene Expression Profiling

Share to Hematologic Neoplasms

Share to Protein Array Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 31811114
DOI: 10.1038/s41408-019-0262-0
PMCID: PMC6898719

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN).PMID 31811114Read ↗

Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience.Semantic proximity Read ↗

TET2 mutations, myelodysplastic features, and a distinct immunoprofile characterize blastic plasmacytoid dendritic cell neoplasm in the bone marrow.Semantic proximity Read ↗

Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm.Semantic proximity Read ↗

Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.Semantic proximity Read ↗

Integrative molecular profiling identifies two molecularly and clinically distinct subtypes of blastic plasmacytoid dendritic cell neoplasmSemantic proximity Read ↗

Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm: DNA Mutations and Epigenetics.Semantic proximity Read ↗

Transcriptomic and genomic heterogeneity in blastic plasmacytoid dendritic cell neoplasms: from ontogeny to oncogenesisSemantic proximity Read ↗

Blastic Plasmacytoid Dendritic Cell Neoplasm: Updates in Diagnostic and Molecular Pathology.Semantic proximity Read ↗

The Clinicopathologic and Genomic Features of Mature Versus Blastic Plasmacytoid Dendritic Cell Neoplasms Arising From Chronic Myeloid Neoplasms.Semantic proximity Read ↗

Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic CellsSemantic proximity Read ↗

Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations.Semantic proximity Read ↗

A Multidisciplinary Approach to Diagnosing Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Practical Recommendations and Insights From Countries of the Gulf Cooperation CouncilSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.